Even as robots took over the show floors, there were clues at CES that robots were not quite ready for prime-time performance, writes ARTHUR GOLDSTUCK.

If that’s too extreme for your tastes, then you might be interested in another project, which instead advocates for poisoning ...

The 2026 AI outlook shows context over prompts and AI moving into robots, guiding you to organize data and ready your staff ...

Sifting the World's Chris DeMuth Jr. discusses value investing and his top thoughts for the new year (0:25). 2 stocks: Willis ...

FROM AI-Powered Farms to Solar-Powered Smart Cities, the Building Blocks of a Digital Nation Are Falling Into Place. For ...

I’ve devoted a good part of 10 years to learning about health, nutrition, and healthy cooking, earning several postgraduate ...

When Elon Musk talks about robotics, he rarely hides the ambition behind the dream. Tesla's Optimus is pitched as an ...

Five CFR fellows examine the challenges that lie ahead, reviewing how governance, adoption, and geopolitical competition will ...

For a company that once rewrote India's smartphone market with ruthless price disruption, Xiaomi India now finds itself in a ...

Marvel Studios has developed a bad habit of killing off big-name characters in the MCU, and these are some of the biggest ...

Venezuela’s interim leader, oil minister Delcy Rodríguez, reportedly asked the U.S. military to seize the tanker because it ...

The European Commission has approved Sanofi’s Teizeild as the first disease-modifying therapy in the EU to delay the onset of stage 3 type 1 diabetes in adults and children with stage 2 T1D. Supported ...